or Try an Advanced Search...

    Liver Disease Stocks List

    Symbol Grade Name % Change
    GALT A Galectin Therapeutics Inc. -1.43
    BLTE C Belite Bio, Inc. 4.61
    GYRE D Gyre Therapeutics, Inc. 4.78
    TARA D ArTara Therapeutics, Inc. -4.10
    MIRM D Mirum Pharmaceuticals, Inc. -0.12
    GNFT F GENFIT S.A. 1.16
    BFRG F Bullfrog AI Holdings, Inc 1.75
    ALGS F Aligos Therapeutics, Inc. -4.40
    NTLA F Intellia Therapeutics, Inc. 3.70
    GILD F Gilead Sciences, Inc. 0.23
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
    Related Stock Lists: Hepatitis Medicine Non Alcoholic Fatty Liver Disease Steatohepatitis Alcohol Biopharmaceutical Hepatology Clinical Medicine Coronavirus Drug Development Fatty Liver Disease Hepatitis B Liver Liver Fibrosis Primary Biliary Cholangitis Pulmonary Arterial Hypertension Acid Amyloid Amyloidosis Angina

    Related ETFs - A few ETFs which own one or more of the above listed Liver Disease stocks.

    Symbol Grade Name Weight
    IBBQ D Invesco Nasdaq Biotechnology ETF 8.48
    IBB D iShares Nasdaq Biotechnology Index Fund 8.47
    BBH D Market Vectors Biotech ETF 7.99
    BIS B ProShares UltraShort Nasdaq Biotechnology 7.41
    BIB D ProShares Ultra Nasdaq Biotechnology 6.12
    View all Liver Disease ETFs...
    Compare ETFs
    Compare BIS to BIB Compare IBB to BIS Compare IBBQ to IBB

        Liver Disease Stocks Recent News

        Date Stock Title
        Apr 27 GILD Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Apr 26 GILD Gilead Sciences declares $0.77 dividend
        Apr 26 GILD Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
        Apr 26 BFRG BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
        Apr 26 GILD Q1 2024 Gilead Sciences Inc Earnings Call
        Apr 26 GILD FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
        Apr 26 BLTE Belite Bio prices $25M direct offering
        Apr 26 GILD Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
        Apr 26 GILD Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
        Apr 26 GILD Gilead Sciences, Inc. (GILD) Q1 2024 Earnings Call Transcript
        Apr 26 GILD Gilead Sciences, Inc. 2024 Q1 - Results - Earnings Call Presentation
        Apr 25 BLTE Belite Bio Announces $25 Million Registered Direct Offering
        Apr 25 GILD Gilead has strong Q1, but updated 2024 EPS guidance range misses consensus
        Apr 25 GILD Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
        Apr 25 GILD Gilead Beats Earnings Expectations After Rocky Quarter
        Apr 25 GILD Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
        Apr 25 GILD Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
        Apr 25 GILD Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
        Apr 25 GILD Gilead Sciences in charts: Revenue from oncology rises most among products; Veklury dips in Q1
        Apr 25 GILD Gilead posts quarterly loss on acquisition charge, revenue rises 5%
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
        Related Stock Lists: Hepatitis Medicine Non Alcoholic Fatty Liver Disease Steatohepatitis Alcohol Biopharmaceutical Hepatology Clinical Medicine Coronavirus Drug Development Fatty Liver Disease Hepatitis B Liver Liver Fibrosis Primary Biliary Cholangitis Pulmonary Arterial Hypertension Acid Amyloid Amyloidosis Angina
        Liver Disease

        Liver disease (also called hepatic disease) is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.

        More about Liver Disease
        Browse All Tags